LIGAND PHARMACEUTICALS (LGND:NASDAQ)
$287.54 -8.75 (-2.9532%)
Analysed LIGAND PHARMACEUTICALS (LGND:NASDAQ) News Sources
Agenus shares surge as company secures up to $340M to advance colon cancer trial
13-07-2026
proactiveinvestors.com
Agenus (AGEN) Moves 82.7% Higher: Will This Strength Last?
14-07-2026
yahoo.com
Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets
14-07-2026
yahoo.com
XOMA Royalty Announces Closing of Its Acquisition by Ligand
14-07-2026
yahoo.com
AGEN Stock Jumps on Securing $340M Financing to Fund Strategic Pivot
14-07-2026
yahoo.com
Ligand Pharmaceuticals (LGND) Stock Looks Undervalued On Cash Flow Yet Overvalued On Earnings
16-07-2026
yahoo.com
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Adobe, Datadog, Five Below, Fortinet, Gilead Sciences, Goldman Sachs, Microsoft, Salesforce, and More
21-07-2026
247wallst.com
Shopify downgraded, Five Below upgraded: Wall Street's top analyst calls
21-07-2026
yahoo.com
Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026
23-07-2026
yahoo.com
This Stock Of The Day Rides Big Pharma Royalties; It's Up 56% In 2026
27-07-2026
yahoo.com
What is the current price of LIGAND PHARMACEUTICALS (LGND:NASDAQ)?
The current price of LIGAND PHARMACEUTICALS (LGND:NASDAQ) is $287.54.
LIGAND PHARMACEUTICALS (LGND:NASDAQ) absolute price change since previous trading day?
The absolute price change of LIGAND PHARMACEUTICALS (LGND:NASDAQ) since the previous trading day is $-8.75.
LIGAND PHARMACEUTICALS (LGND:NASDAQ) percentage price change since previous trading day?
The percentage price change of LIGAND PHARMACEUTICALS (LGND:NASDAQ) since the previous trading day is -2.9532%.
What is the most recent average sentiment score for LIGAND PHARMACEUTICALS (LGND:NASDAQ)?
The most recent average sentiment score for LIGAND PHARMACEUTICALS (LGND:NASDAQ) is 62 out of 100.
What is the most recent average sentiment for LIGAND PHARMACEUTICALS (LGND:NASDAQ)?
The most recent sentiment for LIGAND PHARMACEUTICALS (LGND:NASDAQ) is .
SEC-8K** Filing Available For LIGAND PHARMACEUTICALS (LGND:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.